Share Price and Basic Stock Data
Last Updated: March 13, 2025, 4:05 pm
PEG Ratio | 2.56 |
---|
Competitors of Emami Ltd
Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
---|---|---|---|---|---|---|---|---|---|
Honasa Consumer Ltd | 6,974 Cr. | 214 | 547/197 | 102 | 35.5 | 0.00 % | 17.1 % | % | 10.0 |
Ambica Agarbathies Aroma & Industries Ltd | 47.8 Cr. | 27.8 | 37.0/23.2 | 18.0 | 60.6 | 0.00 % | 5.07 % | 3.65 % | 10.0 |
Ador Multi Products Ltd | 13.2 Cr. | 28.2 | 45.9/23.4 | 23.2 | 0.00 % | 33.6 % | 26.7 % | 10.0 | |
Kaya Ltd | 286 Cr. | 218 | 702/218 | 106 | 0.00 % | 80.4 % | % | 10.0 | |
Jyothy Labs Ltd | 12,144 Cr. | 331 | 596/310 | 32.7 | 51.4 | 1.07 % | 27.0 % | 21.2 % | 1.00 |
Industry Average | 66,127.86 Cr | 1,878.45 | 46.39 | 109.30 | 0.82% | 36.43% | 29.37% | 4.94 |
Quarterly Result
Metric | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 971 | 770 | 773 | 814 | 983 | 836 | 826 | 865 | 996 | 891 | 906 | 891 | 1,049 |
Expenses | 633 | 612 | 604 | 621 | 689 | 636 | 636 | 632 | 682 | 682 | 692 | 645 | 715 |
Operating Profit | 338 | 158 | 169 | 193 | 294 | 199 | 190 | 233 | 314 | 209 | 214 | 246 | 334 |
OPM % | 35% | 21% | 22% | 24% | 30% | 24% | 23% | 27% | 32% | 24% | 24% | 28% | 32% |
Other Income | 17 | 25 | 6 | 42 | 7 | 14 | 8 | 11 | 11 | 11 | 10 | 22 | 15 |
Interest | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 3 | 3 | 2 | 2 | 2 |
Depreciation | 84 | 83 | 88 | 48 | 47 | 64 | 46 | 46 | 46 | 48 | 44 | 45 | 46 |
Profit before tax | 269 | 98 | 85 | 186 | 251 | 148 | 150 | 196 | 276 | 169 | 178 | 220 | 301 |
Tax % | 18% | -262% | 14% | 3% | 7% | 4% | 9% | 8% | 6% | 13% | 16% | 4% | 7% |
Net Profit | 220 | 354 | 73 | 180 | 233 | 142 | 137 | 180 | 261 | 147 | 151 | 211 | 279 |
EPS in Rs | 4.95 | 8.07 | 1.67 | 4.17 | 5.38 | 3.27 | 3.14 | 4.09 | 5.92 | 3.41 | 3.50 | 4.87 | 6.39 |
Last Updated: March 3, 2025, 4:38 pm
Below is a detailed analysis of the quarterly data for Emami Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:
- For Sales, as of Dec 2024, the value is ₹1,049.00 Cr.. The value appears strong and on an upward trend. It has increased from 891.00 Cr. (Sep 2024) to ₹1,049.00 Cr., marking an increase of ₹158.00 Cr..
- For Expenses, as of Dec 2024, the value is ₹715.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 645.00 Cr. (Sep 2024) to ₹715.00 Cr., marking an increase of ₹70.00 Cr..
- For Operating Profit, as of Dec 2024, the value is ₹334.00 Cr.. The value appears strong and on an upward trend. It has increased from 246.00 Cr. (Sep 2024) to ₹334.00 Cr., marking an increase of ₹88.00 Cr..
- For OPM %, as of Dec 2024, the value is 32.00%. The value appears strong and on an upward trend. It has increased from 28.00% (Sep 2024) to 32.00%, marking an increase of 4.00%.
- For Other Income, as of Dec 2024, the value is ₹15.00 Cr.. The value appears to be declining and may need further review. It has decreased from 22.00 Cr. (Sep 2024) to ₹15.00 Cr., marking a decrease of 7.00 Cr..
- For Interest, as of Dec 2024, the value is ₹2.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 2.00 Cr..
- For Depreciation, as of Dec 2024, the value is ₹46.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 45.00 Cr. (Sep 2024) to ₹46.00 Cr., marking an increase of ₹1.00 Cr..
- For Profit before tax, as of Dec 2024, the value is ₹301.00 Cr.. The value appears strong and on an upward trend. It has increased from 220.00 Cr. (Sep 2024) to ₹301.00 Cr., marking an increase of ₹81.00 Cr..
- For Tax %, as of Dec 2024, the value is 7.00%. The value appears to be increasing, which may not be favorable. It has increased from 4.00% (Sep 2024) to 7.00%, marking an increase of 3.00%.
- For Net Profit, as of Dec 2024, the value is ₹279.00 Cr.. The value appears strong and on an upward trend. It has increased from 211.00 Cr. (Sep 2024) to ₹279.00 Cr., marking an increase of ₹68.00 Cr..
- For EPS in Rs, as of Dec 2024, the value is 6.39. The value appears strong and on an upward trend. It has increased from ₹4.87 (Sep 2024) to 6.39, marking an increase of 1.52.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: March 6, 2025, 4:24 pm
Metric | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 1,595 | 1,700 | 2,076 | 2,358 | 2,488 | 2,531 | 2,695 | 2,655 | 2,881 | 3,192 | 3,406 | 3,578 | 3,737 |
Expenses | 1,252 | 1,255 | 1,536 | 1,670 | 1,729 | 1,812 | 1,970 | 1,970 | 2,000 | 2,254 | 2,550 | 2,632 | 2,734 |
Operating Profit | 343 | 445 | 541 | 688 | 759 | 719 | 725 | 685 | 880 | 938 | 855 | 946 | 1,004 |
OPM % | 22% | 26% | 26% | 29% | 31% | 28% | 27% | 26% | 31% | 29% | 25% | 26% | 27% |
Other Income | 54 | 53 | 91 | 44 | 31 | 19 | 25 | 46 | 69 | 90 | 69 | 41 | 58 |
Interest | 7 | 5 | 5 | 54 | 58 | 34 | 21 | 21 | 13 | 5 | 7 | 10 | 9 |
Depreciation | 22 | 35 | 34 | 255 | 309 | 311 | 325 | 336 | 367 | 335 | 247 | 186 | 183 |
Profit before tax | 369 | 457 | 592 | 423 | 424 | 393 | 403 | 374 | 569 | 688 | 670 | 791 | 869 |
Tax % | 15% | 12% | 18% | 14% | 20% | 22% | 25% | 19% | 20% | -22% | 6% | 8% | |
Net Profit | 315 | 402 | 485 | 363 | 340 | 306 | 303 | 302 | 455 | 837 | 627 | 724 | 787 |
EPS in Rs | 6.93 | 8.87 | 10.70 | 8.00 | 7.50 | 6.77 | 6.68 | 6.67 | 10.23 | 19.02 | 14.50 | 16.58 | 18.17 |
Dividend Payout % | 38% | 39% | 33% | 44% | 47% | 52% | 60% | 60% | 78% | 42% | 55% | 48% |
YoY Net Profit Growth
Year | 2013-2014 | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 |
---|---|---|---|---|---|---|---|---|---|---|---|
YoY Net Profit Growth (%) | 27.62% | 20.65% | -25.15% | -6.34% | -10.00% | -0.98% | -0.33% | 50.66% | 83.96% | -25.09% | 15.47% |
Change in YoY Net Profit Growth (%) | 0.00% | -6.97% | -45.80% | 18.82% | -3.66% | 9.02% | 0.65% | 50.99% | 33.29% | -109.05% | 40.56% |
Emami Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.
Growth
Compounded Sales Growth | |
---|---|
10 Years: | 8% |
5 Years: | 6% |
3 Years: | 8% |
TTM: | 6% |
Compounded Profit Growth | |
---|---|
10 Years: | 6% |
5 Years: | 19% |
3 Years: | 18% |
TTM: | 9% |
Stock Price CAGR | |
---|---|
10 Years: | 1% |
5 Years: | 22% |
3 Years: | 5% |
1 Year: | 29% |
Return on Equity | |
---|---|
10 Years: | 27% |
5 Years: | 28% |
3 Years: | 33% |
Last Year: | 30% |
Last Updated: Unknown
Balance Sheet
Last Updated: November 15, 2024, 12:35 am
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 15 | 23 | 23 | 23 | 23 | 23 | 45 | 45 | 44 | 44 | 44 | 44 | 44 |
Reserves | 762 | 909 | 1,208 | 1,589 | 1,732 | 1,991 | 2,031 | 1,778 | 1,718 | 2,032 | 2,259 | 2,403 | 2,585 |
Borrowings | 115 | 38 | 36 | 671 | 473 | 326 | 110 | 210 | 101 | 282 | 91 | 94 | 74 |
Other Liabilities | 324 | 333 | 410 | 409 | 376 | 458 | 633 | 644 | 656 | 692 | 703 | 728 | 891 |
Total Liabilities | 1,216 | 1,302 | 1,676 | 2,692 | 2,603 | 2,798 | 2,819 | 2,678 | 2,520 | 3,050 | 3,096 | 3,269 | 3,594 |
Fixed Assets | 397 | 396 | 453 | 1,918 | 1,994 | 1,802 | 1,680 | 1,459 | 1,132 | 1,344 | 1,245 | 1,114 | 1,039 |
CWIP | 47 | 12 | 29 | 67 | 22 | 30 | 36 | 8 | 6 | 3 | 6 | 8 | 9 |
Investments | 163 | 296 | 501 | 104 | 128 | 314 | 187 | 156 | 255 | 303 | 293 | 442 | 624 |
Other Assets | 609 | 599 | 693 | 604 | 460 | 652 | 915 | 1,055 | 1,126 | 1,400 | 1,551 | 1,706 | 1,922 |
Total Assets | 1,216 | 1,302 | 1,676 | 2,692 | 2,603 | 2,798 | 2,819 | 2,678 | 2,520 | 3,050 | 3,096 | 3,269 | 3,594 |
Below is a detailed analysis of the balance sheet data for Emami Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2024, the value is ₹44.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹44.00 Cr..
- For Reserves, as of Sep 2024, the value is ₹2,585.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹2,403.00 Cr. (Mar 2024) to ₹2,585.00 Cr., marking an increase of 182.00 Cr..
- For Borrowings, as of Sep 2024, the value is ₹74.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from ₹94.00 Cr. (Mar 2024) to ₹74.00 Cr., marking a decrease of 20.00 Cr..
- For Other Liabilities, as of Sep 2024, the value is ₹891.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹728.00 Cr. (Mar 2024) to ₹891.00 Cr., marking an increase of 163.00 Cr..
- For Total Liabilities, as of Sep 2024, the value is ₹3,594.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹3,269.00 Cr. (Mar 2024) to ₹3,594.00 Cr., marking an increase of 325.00 Cr..
- For Fixed Assets, as of Sep 2024, the value is ₹1,039.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹1,114.00 Cr. (Mar 2024) to ₹1,039.00 Cr., marking a decrease of 75.00 Cr..
- For CWIP, as of Sep 2024, the value is ₹9.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹8.00 Cr. (Mar 2024) to ₹9.00 Cr., marking an increase of 1.00 Cr..
- For Investments, as of Sep 2024, the value is ₹624.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹442.00 Cr. (Mar 2024) to ₹624.00 Cr., marking an increase of 182.00 Cr..
- For Other Assets, as of Sep 2024, the value is ₹1,922.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹1,706.00 Cr. (Mar 2024) to ₹1,922.00 Cr., marking an increase of 216.00 Cr..
- For Total Assets, as of Sep 2024, the value is ₹3,594.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹3,269.00 Cr. (Mar 2024) to ₹3,594.00 Cr., marking an increase of 325.00 Cr..
Notably, the Reserves (₹2,585.00 Cr.) exceed the Borrowings (74.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow | 228.00 | 407.00 | 505.00 | 17.00 | 286.00 | 393.00 | 615.00 | 475.00 | 779.00 | 656.00 | 764.00 | 852.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 26 | 17 | 18 | 20 | 14 | 22 | 29 | 42 | 29 | 37 | 44 | 50 |
Inventory Days | 58 | 76 | 59 | 68 | 83 | 87 | 88 | 102 | 118 | 121 | 100 | 102 |
Days Payable | 52 | 77 | 90 | 112 | 85 | 109 | 115 | 135 | 138 | 138 | 126 | 143 |
Cash Conversion Cycle | 32 | 16 | -13 | -24 | 12 | 1 | 2 | 9 | 10 | 19 | 18 | 9 |
Working Capital Days | -7 | -6 | -13 | 3 | -37 | 15 | 9 | 36 | 9 | 31 | 37 | 55 |
ROCE % | 42% | 50% | 61% | 30% | 23% | 22% | 19% | 18% | 29% | 31% | 28% |
Mutual Fund Holdings
Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
---|---|---|---|---|---|---|
Kotak Emerging Equity Fund - Regular Plan | 8,135,375 | 1.13 | 508.87 | 7,419,485 | 2025-03-12 | 9.65% |
HDFC Mid-Cap Opportunities Fund - Regular Plan | 7,419,485 | 0.71 | 464.09 | 7,419,485 | 2025-03-12 | 0% |
Nippon India Small Cap Fund | 7,360,252 | 0.89 | 460.38 | 7,419,485 | 2025-03-12 | -0.8% |
SBI Large & Midcap Fund | 6,500,000 | 1.73 | 406.58 | 7,419,485 | 2025-03-12 | -12.39% |
DSP Mid Cap Fund | 5,265,742 | 1.86 | 329.37 | 7,419,485 | 2025-03-12 | -29.03% |
DSP ELSS Tax Saver Fund | 4,224,369 | 1.74 | 264.23 | 7,419,485 | 2025-03-12 | -43.06% |
Franklin India Prima Fund | 3,676,225 | 2.09 | 229.95 | 7,419,485 | 2025-03-12 | -50.45% |
HDFC Small Cap Fund - Regular Plan | 3,365,892 | 0.72 | 210.54 | 7,419,485 | 2025-03-12 | -54.63% |
DSP Equity Opportunities Fund | 2,906,650 | 1.52 | 181.81 | 7,419,485 | 2025-03-12 | -60.82% |
Franklin India Smaller Companies Fund | 2,750,000 | 1.34 | 172.01 | 7,419,485 | 2025-03-12 | -62.94% |
Key Financial Ratios
Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
---|---|---|---|---|---|
FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Basic EPS (Rs.) | 16.55 | 14.50 | 18.88 | 10.23 | 6.67 |
Diluted EPS (Rs.) | 16.55 | 14.50 | 18.88 | 10.23 | 6.67 |
Cash EPS (Rs.) | 20.93 | 20.00 | 26.88 | 18.58 | 14.23 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 56.30 | 52.43 | 47.02 | 39.63 | 40.22 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 56.30 | 52.43 | 47.02 | 39.63 | 40.22 |
Revenue From Operations / Share (Rs.) | 81.97 | 77.20 | 72.36 | 64.80 | 58.58 |
PBDIT / Share (Rs.) | 22.83 | 21.12 | 23.75 | 21.45 | 16.50 |
PBIT / Share (Rs.) | 18.57 | 15.51 | 16.16 | 13.19 | 9.08 |
PBT / Share (Rs.) | 18.20 | 15.35 | 15.93 | 12.89 | 8.38 |
Net Profit / Share (Rs.) | 16.67 | 14.39 | 19.30 | 10.32 | 6.80 |
NP After MI And SOA / Share (Rs.) | 16.58 | 14.50 | 19.02 | 10.23 | 6.68 |
PBDIT Margin (%) | 27.84 | 27.35 | 32.81 | 33.09 | 28.16 |
PBIT Margin (%) | 22.64 | 20.09 | 22.33 | 20.35 | 15.49 |
PBT Margin (%) | 22.20 | 19.87 | 22.01 | 19.89 | 14.29 |
Net Profit Margin (%) | 20.34 | 18.64 | 26.66 | 15.93 | 11.61 |
NP After MI And SOA Margin (%) | 20.22 | 18.77 | 26.28 | 15.78 | 11.40 |
Return on Networth / Equity (%) | 29.57 | 27.77 | 40.40 | 25.79 | 16.60 |
Return on Capital Employeed (%) | 32.14 | 28.68 | 33.28 | 32.22 | 21.80 |
Return On Assets (%) | 22.06 | 20.56 | 27.44 | 18.04 | 11.30 |
Total Debt / Equity (X) | 0.02 | 0.03 | 0.12 | 0.05 | 0.11 |
Asset Turnover Ratio (%) | 1.12 | 1.00 | 1.07 | 1.04 | 0.90 |
Current Ratio (X) | 1.87 | 1.78 | 1.17 | 1.61 | 1.30 |
Quick Ratio (X) | 1.44 | 1.32 | 0.78 | 1.18 | 0.99 |
Inventory Turnover Ratio (X) | 2.36 | 2.43 | 2.72 | 2.65 | 3.17 |
Dividend Payout Ratio (NP) (%) | 48.26 | 55.18 | 42.38 | 78.20 | 119.88 |
Dividend Payout Ratio (CP) (%) | 38.39 | 39.79 | 30.29 | 43.27 | 56.80 |
Earning Retention Ratio (%) | 51.74 | 44.82 | 57.62 | 21.80 | -19.88 |
Cash Earning Retention Ratio (%) | 61.61 | 60.21 | 69.71 | 56.73 | 43.20 |
Interest Coverage Ratio (X) | 99.86 | 126.05 | 206.51 | 71.83 | 35.58 |
Interest Coverage Ratio (Post Tax) (X) | 74.54 | 86.90 | 169.83 | 35.58 | 16.18 |
Enterprise Value (Cr.) | 18339.38 | 0.00 | 19900.10 | 21407.37 | 7794.39 |
EV / Net Operating Revenue (X) | 5.13 | 0.00 | 6.23 | 7.43 | 2.94 |
EV / EBITDA (X) | 18.41 | 0.00 | 19.00 | 22.46 | 10.43 |
MarketCap / Net Operating Revenue (X) | 5.16 | 0.00 | 6.19 | 7.53 | 2.90 |
Retention Ratios (%) | 51.73 | 44.81 | 57.61 | 21.79 | -19.88 |
Price / BV (X) | 7.55 | 0.00 | 9.51 | 12.30 | 4.22 |
Price / Net Operating Revenue (X) | 5.16 | 0.00 | 6.19 | 7.53 | 2.90 |
EarningsYield | 0.03 | 0.00 | 0.04 | 0.02 | 0.03 |
After reviewing the key financial ratios for Emami Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 24, the value is 16.55. This value is within the healthy range. It has increased from 14.50 (Mar 23) to 16.55, marking an increase of 2.05.
- For Diluted EPS (Rs.), as of Mar 24, the value is 16.55. This value is within the healthy range. It has increased from 14.50 (Mar 23) to 16.55, marking an increase of 2.05.
- For Cash EPS (Rs.), as of Mar 24, the value is 20.93. This value is within the healthy range. It has increased from 20.00 (Mar 23) to 20.93, marking an increase of 0.93.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 56.30. It has increased from 52.43 (Mar 23) to 56.30, marking an increase of 3.87.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 56.30. It has increased from 52.43 (Mar 23) to 56.30, marking an increase of 3.87.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 81.97. It has increased from 77.20 (Mar 23) to 81.97, marking an increase of 4.77.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 22.83. This value is within the healthy range. It has increased from 21.12 (Mar 23) to 22.83, marking an increase of 1.71.
- For PBIT / Share (Rs.), as of Mar 24, the value is 18.57. This value is within the healthy range. It has increased from 15.51 (Mar 23) to 18.57, marking an increase of 3.06.
- For PBT / Share (Rs.), as of Mar 24, the value is 18.20. This value is within the healthy range. It has increased from 15.35 (Mar 23) to 18.20, marking an increase of 2.85.
- For Net Profit / Share (Rs.), as of Mar 24, the value is 16.67. This value is within the healthy range. It has increased from 14.39 (Mar 23) to 16.67, marking an increase of 2.28.
- For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 16.58. This value is within the healthy range. It has increased from 14.50 (Mar 23) to 16.58, marking an increase of 2.08.
- For PBDIT Margin (%), as of Mar 24, the value is 27.84. This value is within the healthy range. It has increased from 27.35 (Mar 23) to 27.84, marking an increase of 0.49.
- For PBIT Margin (%), as of Mar 24, the value is 22.64. This value exceeds the healthy maximum of 20. It has increased from 20.09 (Mar 23) to 22.64, marking an increase of 2.55.
- For PBT Margin (%), as of Mar 24, the value is 22.20. This value is within the healthy range. It has increased from 19.87 (Mar 23) to 22.20, marking an increase of 2.33.
- For Net Profit Margin (%), as of Mar 24, the value is 20.34. This value exceeds the healthy maximum of 10. It has increased from 18.64 (Mar 23) to 20.34, marking an increase of 1.70.
- For NP After MI And SOA Margin (%), as of Mar 24, the value is 20.22. This value exceeds the healthy maximum of 20. It has increased from 18.77 (Mar 23) to 20.22, marking an increase of 1.45.
- For Return on Networth / Equity (%), as of Mar 24, the value is 29.57. This value is within the healthy range. It has increased from 27.77 (Mar 23) to 29.57, marking an increase of 1.80.
- For Return on Capital Employeed (%), as of Mar 24, the value is 32.14. This value is within the healthy range. It has increased from 28.68 (Mar 23) to 32.14, marking an increase of 3.46.
- For Return On Assets (%), as of Mar 24, the value is 22.06. This value is within the healthy range. It has increased from 20.56 (Mar 23) to 22.06, marking an increase of 1.50.
- For Total Debt / Equity (X), as of Mar 24, the value is 0.02. This value is within the healthy range. It has decreased from 0.03 (Mar 23) to 0.02, marking a decrease of 0.01.
- For Asset Turnover Ratio (%), as of Mar 24, the value is 1.12. It has increased from 1.00 (Mar 23) to 1.12, marking an increase of 0.12.
- For Current Ratio (X), as of Mar 24, the value is 1.87. This value is within the healthy range. It has increased from 1.78 (Mar 23) to 1.87, marking an increase of 0.09.
- For Quick Ratio (X), as of Mar 24, the value is 1.44. This value is within the healthy range. It has increased from 1.32 (Mar 23) to 1.44, marking an increase of 0.12.
- For Inventory Turnover Ratio (X), as of Mar 24, the value is 2.36. This value is below the healthy minimum of 4. It has decreased from 2.43 (Mar 23) to 2.36, marking a decrease of 0.07.
- For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 48.26. This value is within the healthy range. It has decreased from 55.18 (Mar 23) to 48.26, marking a decrease of 6.92.
- For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 38.39. This value is within the healthy range. It has decreased from 39.79 (Mar 23) to 38.39, marking a decrease of 1.40.
- For Earning Retention Ratio (%), as of Mar 24, the value is 51.74. This value is within the healthy range. It has increased from 44.82 (Mar 23) to 51.74, marking an increase of 6.92.
- For Cash Earning Retention Ratio (%), as of Mar 24, the value is 61.61. This value is within the healthy range. It has increased from 60.21 (Mar 23) to 61.61, marking an increase of 1.40.
- For Interest Coverage Ratio (X), as of Mar 24, the value is 99.86. This value is within the healthy range. It has decreased from 126.05 (Mar 23) to 99.86, marking a decrease of 26.19.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 74.54. This value is within the healthy range. It has decreased from 86.90 (Mar 23) to 74.54, marking a decrease of 12.36.
- For Enterprise Value (Cr.), as of Mar 24, the value is 18,339.38. It has increased from 0.00 (Mar 23) to 18,339.38, marking an increase of 18,339.38.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 5.13. This value exceeds the healthy maximum of 3. It has increased from 0.00 (Mar 23) to 5.13, marking an increase of 5.13.
- For EV / EBITDA (X), as of Mar 24, the value is 18.41. This value exceeds the healthy maximum of 15. It has increased from 0.00 (Mar 23) to 18.41, marking an increase of 18.41.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 5.16. This value exceeds the healthy maximum of 3. It has increased from 0.00 (Mar 23) to 5.16, marking an increase of 5.16.
- For Retention Ratios (%), as of Mar 24, the value is 51.73. This value is within the healthy range. It has increased from 44.81 (Mar 23) to 51.73, marking an increase of 6.92.
- For Price / BV (X), as of Mar 24, the value is 7.55. This value exceeds the healthy maximum of 3. It has increased from 0.00 (Mar 23) to 7.55, marking an increase of 7.55.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 5.16. This value exceeds the healthy maximum of 3. It has increased from 0.00 (Mar 23) to 5.16, marking an increase of 5.16.
- For EarningsYield, as of Mar 24, the value is 0.03. This value is below the healthy minimum of 5. It has increased from 0.00 (Mar 23) to 0.03, marking an increase of 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Strength | Weakness |
---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Emami Ltd:
- Net Profit Margin: 20.34%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 32.14% (Industry Average ROCE: 36.43%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 29.57% (Industry Average ROE: 25.7%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 74.54
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.44
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 31.2 (Industry average Stock P/E: 37.69)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.02
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 20.34%
About the Company - Qualitative Analysis
INDUSTRY | ADDRESS | CONTACT |
---|---|---|
Industry not found | Address not found | Contact not found |
FAQ
What is the latest intrinsic value of Emami Ltd?
The latest intrinsic value of Emami Ltd as on 13 March 2025 is 457.18, which is 18.65% lower than the current market price of ₹562.00, indicating the stock is overvalued by 18.65%. The intrinsic value of Emami Ltd is calculated using PE ratio method. The stock has a market capitalization of ₹24,538 Cr. and recorded a high/low of ₹860/417 during the current fiscal year 2024-2025. As of Sep 2024, the company has reserves of ₹2,585 Cr and total liabilities of ₹3,594 Cr.
What is the Market Cap of Emami Ltd?
The Market Cap of Emami Ltd is 24,538 Cr..
What is the current Stock Price of Emami Ltd as on 13 March 2025?
The current stock price of Emami Ltd as on 13 March 2025 is ₹562.
What is the High / Low of Emami Ltd stocks in FY 2024-2025?
In FY 2024-2025, the High / Low of Emami Ltd stocks is ₹860/417.
What is the Stock P/E of Emami Ltd?
The Stock P/E of Emami Ltd is 31.2.
What is the Book Value of Emami Ltd?
The Book Value of Emami Ltd is 60.2.
What is the Dividend Yield of Emami Ltd?
The Dividend Yield of Emami Ltd is 1.42 %.
What is the ROCE of Emami Ltd?
The ROCE of Emami Ltd is 31.7 %.
What is the ROE of Emami Ltd?
The ROE of Emami Ltd is 30.0 %.
What is the Face Value of Emami Ltd?
The Face Value of Emami Ltd is 1.00.